Upload
others
View
8
Download
0
Embed Size (px)
Citation preview
doi:10.1016/j.jmb.2005.03.013 J. Mol. Biol. (xxxx) xx, 1–12
DTD 5 ARTICLE IN PRESS
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
Induction of Inflammatory Cytokines by Double-stranded and Single-stranded siRNAs is Sequence-dependent and Requires Endosomal Localization
Mouldy Sioud*
78
79
80
81
82
83
Department of ImmunologyMolecular Medicine GroupThe Norwegian RadiumHospital, Montebello, N-0310Oslo, Norway
UNC
0022-2836/$ - see front matter q 2005 E
Abbreviations used: DC, dendriticdendritic cells; siRNA, small-interfeRNA interference; PKR, protein kinreceptor; IL, interleukin-; TNF-a, tuNF-kB, nuclear factor NF-kappa B;DOTAP, N-[1-(2,3-Dioleoyloxy)propammoniunmmethyl-sulfate.E-mail address of the author mos
YJMBI 57125—21/3/2005—17:11—SFORSTER
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
RE
CTED
PRO
OF
The potential induction of inflammatory cytokines and interferonresponses by small-interfering RNAs (siRNAs) represents a major obstaclefor their use as inhibitors of gene expression. Therapeutic applications ofsiRNAs will require a better understanding of the mechanisms that triggersuch unwanted effects, especially in freshly isolated human cells.Surprisingly, the induction of tumor necrosis factor (TNF-a) andinterleukin-6 (IL-6) in adherent peripheral blood mononuclear cells(PBMC) was not restricted to double-stranded siRNAs, because inductionwas also obtained with single-stranded siRNAs (sense or antisensestrands). The immunostimulatory effects were sequence-dependent, sinceonly certain sequences are prone to induce inflammatory responses whileother not. The induction of TNF-a, IL-6 and interferon a (IFN-a) waschloroquine sensitive and dependent more likely on endosomal Toll-likereceptor signaling. Indeed, no significant immunostimulatory effects weredetected when either double or single-stranded siRNAs were delivereddirectly to cytoplasm via electroporation. Both RNA types activated aNF-kB promoter-driven luciferase gene in transiently transfected humanadherent PBMC. Moreover, culture of immature dendritic cells with eitherdouble or single-stranded siRNAs stimulated interleukin-12 productionand induced the expression of CD83, an activation marker. Interestingly,several double-stranded siRNAs did not induced TNF-a, IL-6 and IFN-aproduction, however, their single-stranded sense or antisense did. Takentogether, the present data indicate for the first time that the inductioninflammatory cytokines and IFN-a responses by either double-stranded orsingle-stranded siRNAs in adherent PBMC is sequence-dependent andrequires endosomal intracellular signaling. The finding that endosomallocalization of self-RNAs (sense strands) can trigger Toll-like receptorsignaling in adherent human PBMC is intriguing because it indicates thatendosomal self-RNAs can display a molecular pattern capable foractivating innate immunity.
q 2005 Elsevier Ltd. All rights reserved.
Keywords: RNA interference; siRNAs; innate immunity; Toll-like receptors;inflammatory cytokines
113
R*Corresponding author
114
115
116
117
OIntroductionRNA interference (RNAi) is an evolutionarily
lsevier Ltd. All rights reserve
cells; iDC, immaturering RNA; RNAi,ase R; TLR, Toll-likemor necrosis factor a;INF, interferon;yl]-N,N,N-trimethyl-
—141115—XML – pp. 1–12/APP
118
119
120
121
122
123
124
125
126
conserved post-transcriptional gene-silencing pro-cess, resulting in specific mRNA degradation inseveral organisms.1,2 In this process, long double-stranded (ds) RNAs were processed by the RNaseIII-like enzyme Dicer to 21–25 nucleotides small-interfering RNAs (siRNAs), which are then incor-porated into a protein complex, the RNA-inducedsilencing complex (RISC). Thereafter, the RISC isremodulated into its active form, which contains theproteins necessary for cleaving the target mRNA atthe site, where the guide antisense siRNA strandbinds.2 RNAi and the related phenomenon of
d.
S
2
DTD 5 ARTICLE IN PRESS
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
quelling and post-transcriptional gene silencing(PTGS) have been shown to exist in fungus(Neurospora), plants (Arabidopsis), invertebrates(Drosophila and C. elegans) and embryonic mouseand human cells.2,3 Notably, the cellular role ofRNAi is to maintain the integrity of the genome, todefend cells against viral infection, and to regulatethe expression of cellular genes.
In general RNAi was difficult to detect in somaticmammalian cells, since dsRNA structures greaterthan 30 bp stimulate the IFN pathway, whichrepresents a host response to viral infection whereseveral genes are activated.4 Much of the interferonresponses are caused by the activation of thedsRNA-dependent protein kinase R (PKR). Theantiviral effect of PKR is in part mediated throughthe phosphorylation of the alpha subunit of theeukaryotic translation initiation factor eIF2a, whichresults in the sequestration of the recycling factoreIF-2b in an inactive complex together with eIF2a-GDP.5 The net effect is global inhibition of proteinsynthesis. However, it has recently been shown thatsynthetic 21 nt siRNAs, the effector in RNAi,transfected into human somatic cells can effectivelybypass activation of the interferon pathway.6 Sincethen siRNAs have become a powerful tool forgenetic analysis and might serve as a potenttherapeutic tool for gene silencing.7,8 In additionto mRNA cleavage, siRNAs can induce chromatinmodification in different organisms. Interestingly, arecent report specified a function for siRNAs in
UNCO
RREC
T
Table 1. Sequences of the siRNAs used in this study
SiRNAs Sequence (5 0–3 0) (sense strand)
1 GGCCUUCCUACCUUCAGACTT2 GAUCAUCUUCUCAAAAUUCTT3 GUUCACCUGAGCCUAAUAGTT4 CUGAUGACCAGCAACUUGATT5 GACAACCAACUAGUGGUGCTT9 GAGGCUGAGACAUAGGCACTT7 GAACUGAUGACAGGGAGGCTT8 GAAGAAGUCGUGCUGCCUUTT9 GGUGACAAGAACAUCUCCATT10 GACCUCAUGUACCACAUUCTT11 GCCAUUGCACUGUGAAUACTT12 GUGAUCAUUCAGAGCCAGCTT13 GGCAUCUGGCUUAAGGUGATT14 GACCCUCGAGUCAACAGAGTT15 GCAUGCCUUGGAAUUCCUUTT16 GGCCGAUUGAUCUCAGCGCTT17 GGCCAAAUUUACAUUCUCCTT18 CCAACUAUGACCAGGAUAATT19 GUAGAUCAAUACCCUACACTT20 GGAGCGCACCAUCUUCUUCTT21 GACUUGAGCGAGCGCUUUUTT22 GAGAUGAUACCACCUGAAATT23 GCAGAUCUGCGUCGGCCAGTT24 GGUUCCAUCGAAUCCUGCATT25 GAGGCAAUCACCAAUAGCATT26 GAAGAUUUGCGCAGUGGACTT27 GUCCGGGCAGGUCUACUUUTT28 GGCAUGGAUCUCAAAGACATT29 CCAACGGCAUGGAUCUCAATT30 UGCCCUUCUACAACCAGGATT31 GCUGGAGUACAACUACAACTT32 GCUGGAGAUCCUGAAGAACTT
YJMBI 57125—21/3/2005—17:11—SFORSTER—141115—XML – pp. 1–12/A
DNAmethylation in mammalian cells.9 Contrary towhat was thought; recent experiments indicate thatexogenously delivered siRNAs can activate theinterferon pathway.10–15 However, there are con-flicting reports regarding the extent of off-targeteffects and interferon induction by siRNA inmammalian cells. For example, Rossi and col-leagues noted that none of the three testedchemically made siRNAs induced interferonresponses in human cells.16 These differencescould be due to several factors, including differ-ences in the cell types, reagent preparations andsiRNA sequences. Notably, in all studies only a fewsiRNAs were tested using the same experimentalconditions. To further address the question of whatdetermines siRNA stimulatory function, a compre-hensive analysis of 32 siRNAs targeting differentgenes was performed. The results indicate that thestimulating capacities of either double-stranded,single-stranded sense or antisense siRNAs aresequence dependent and require endosomal com-partments for intracellular signaling.
FResults and Discussion
OOThe non-specific effects of siRNAs aresequence-dependent
siRNA were initially thought to be small enoughto avoid double-stranded RNA responses.6
ED P
RTarget gene
Mouse TNF-aMouse TNF-aHuman HIF-1Human HIF-1Mouse TNF-aMouse TNF-aScrambled siRNAScrambled siRNAHuman neuropilin-1Human PKC-aMouse Csf-1Mouse Csf-1 receptorMouse Csf-1 receptorMouse Csf-1Scrambled siRNAHuman TNF-aRat NG-2Human MMP-9Rat NG-2GFPHuman C20orf55Human CSPPHuman Frizzled-2Human Wnt-1Mouse BasiginHuman CSPPMouse TNF-aMouse TNF-aMouse TNF-aHuman AKT-1GFPHuman cDNA FLJ34902
PPS
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
3
DTD 5 ARTICLE IN PRESS
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
However, recent studies indicated that they couldinduce interferons and cytokine responses.10–15
Although the reported data provide a note ofcaution, the activation of the non-specific pathwaysby siRNAs is not well understood. We havepreviously examined the response of BALB/cmice to systemic delivery of siRNAs and foundinduction of TNF-a and IL-6 by larger RNAs andLPS, but not with a chemically synthesizedsiRNA.15 whilst the same siRNA preparationinduced inflammatory cytokine responses in
UNCO
RREC
T
YJMBI 57125—21/3/2005—17:11—SFORSTER—141115—XML – pp. 1–12/APP
adherent PBMC in vitro.15 To assess whether thesiRNA non-specific effects are sequence-dependentand to uncover themolecular mechanisms bywhichsiRNA activate innate immuniy genes, the induc-tion of TNF-a and IL-6 secretion by 32 differentsiRNAs was examined in adherent PBMC, anenriched monocyte population. Freshly isolatedcells were treated with the various siRNAsequences (see Table 1) for 18 hours. SpecificELISA on culture supernatants revealed thataround 50% of the tested siRNAs induced the
ED P
ROOF
Figure 1. Effects of siRNAs uponTNF-a and IL-6 production inadherent PBMC. Cells were trans-fected with the indicated siRNAsmolecules (100 nM) for 18 hoursand then TNF-a (a) and IL-6(b) were measured in the super-natants by ELISA. Results areshown as means of five indepen-dent experiments GSD. Thesequences of the used siRNAs areshown in Table 1. (c) Immunosti-mulatory siRNA induce TNF-aproduction in a dose dependentmanner. Adherent PBMC weretransfected with various concen-trations (5–200 nM) of eithersiRNA 27 for 18 hours. Subse-quently, TNF-a was measured inthe supernatants by ELISA. Allresults represent the mean of fouror more independent experiments.D, cells were incubated with onlyDOTAP and transfection buffer.
S
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
T
F
Figure 2. Characterization ofsiRNA effects. (a) siRNA inducedTNF-a production required lipo-somal delivery of siRNAs. Adher-ent PBMC were incubated for 18hours with either siRNA liposomecomplexes or naked siRNA 27(100 nM) in X-VIVO 15 medium,a nuclease free medium. Subse-quently, TNF-a was measured inthe supernatants by ELISA.Results are shown as means offour independent experimentsGSD. (b) Inhibition of PKR.Adherent PBMC were pretreated,or not, with 2-aminopurine(10 mM) for one hour prior incu-bation with either siRNA 27 or 32(100 nM) for 18 hours. Subse-quently, TNF-a was measured inthe supernatants by ELISA.Results are shown as means offour independent experiments
GSD. (c) siRNA induced TNF-a production in blood monocytes. Purified CD14-positive cells were incubated witheither siRNA 27 or 32 (100 nM) for 18 hours, and then TNF-awas measured in the supernatants using ELISA. All resultsrepresent the mean of four or more independent experiments
4
DTD 5 ARTICLE IN PRESS
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
UNCO
RREC
production of TNF-a(Figure 1(a)). Adherent PBMCproduced also IL-6 upon stimulation with siRNAscomplexed to DOTAP (Figure 1(b)). The profile ofIL-6 production is comparable to that of TNF-a.Notably, siRNAs varied dramatically in their abilityto induce TNF-a and IL-6 production, suggestingthat their activities are sequence-dependent. Onlysix of the siRNAs examined exhibited a strongimmunostimulatory effect, with siRNA-27 being themost effective under our experimental conditions.
To determine the immunostimulatory capacity ofsiRNAs, cells were transfected with siRNA 27 at arange of concentrations (5–200 nM). After 18 hoursin culture, secreted TNF-a was assessed by ELISA(Figure 1(c)). As shown, siRNA 27 stimulatedTNF-a production even at low concentrations.Taken together these data indicate that siRNAscan activate the expression of inflammatory cyto-kines, but their affinity and specificity for a potentialcellular target are more likely to be influenced bythe siRNA base composition. Sequence alignmentof the siRNA sequences revealed no significanthomology between the immunostimulatory siR-NAs, suggesting the involvement of RNA tertiarystructures and/or specific dinucleotides.
Intracellular siRNA delivery is required forcytokine induction
Having found that the non-specific effects ofsiRNAs are sequence-dependent, I have nextinvestigated whether intracellular siRNA deliverywas required. Therefore siRNAs were addeddirectly to the culture medium without complexingthem to DOTAP. siRNA 27 activated adherentPMBC to secrete TNF-a when complexed toDOTAP. In contrast, free siRNA did not lead to
YJMBI 57125—21/3/2005—17:11—SFORSTER—141115—XML – pp. 1–12/A
ED P
ROOsignificant cytokine production (Figure 2(a)).A nuclease resistant siRNA 27 gave similar results
as its unmodified version (data not shown). Theseresults argue that siRNAs target mainly intra-cellular compounds. In this respect, a role for PKRin the activation of interferons by siRNAs wasrecently suggested.12
To explore the involvement of the dsRNArecognition protein PKR in this process, the specificinhibitor of PKR, 2-aminopurine, was used. Cellswere pretreated with 2-aminopurine (10 mM), anormally used concentration, and subsequentlytreated with siRNA liposome complexes. Pretreat-ment with 2-aminopurine reduced, but did notabolish cytokine production by siRNAs (Figure2(b)). These results would indicate the involvementof other cellular targets in siRNA intracellularsignaling.
siRNAs activate TNF-a production in purifiedhuman monocytes
Monocytes are essential effector cells in chronicinflammatory disorders and infectious diseases. Toperform their function, monocytes need to beactivated, either via inflammatory cytokines pro-duced by the adaptive immune system or via directstimulation with microbial products. Although ahigh proportion of the adherent PBMC are mono-cytes, the capacity of siRNAs to activate TNF-aproduction in purified blood monocytes wasinvestigated. In these experiments, CD14-positivecell populations were prepared from PBMC bypositive selection with immunomagnetic beadscoated with anti-CD14 monoclonal antibodies(Dynal, Oslo, Norway), and the cells were subse-quently incubated with siRNAs (Figure 2(c)). There
PPS
RREC
TED
PROO
F
Figure 3. Expression of TLR3 by human monocytes and iDC. (a) Flow cytometry analysis. Freshly isolated monocytesand iDC, monocytes cultured for six days in the presence of GM-CSF and IL-4, were stained either with FITC-labeledanti-TLR3 monoclonal antibody (eBioscience) or control mouse IgG1. After washing, cells were analyzed by flowcytometry. The mean fluorescence of stained cells is shown in the upper-right corner of the individual dot plots. (b) RT-PCR for TLR3 and actin mRNAwas performedwith monocytes and iDC as described in Experimental Procedures. TLR3was not detected in human monocytes.
5
DTD 5 ARTICLE IN PRESS
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
COwas a significant induction of TNF-a productionwith the immunostimulatory siRNA 27, whereas nosignificant activity was seen with the control siRNA32.623
624
625
626
627
628
629
630
UNTLR3 is not required for responsiveness toeither double-stranded or single-strandedsiRNAs in adherent PBMCNotably, the host sensors that initially detect viral
and bacterial antigens and trigger cytokine pro-duction has been investigated by several groups,
YJMBI 57125—21/3/2005—17:11—SFORSTER—141115—XML – pp. 1–12/APP
some of which have indicated the involvement ofToll-like receptors (TLRs). These receptors, whichare mammalian homologous of the Drosophila Toll,recognize specific structural motifs expressed bymicrobes.17–19 So far, ten TLRs have been describedin humans, and ligands have been defined for nineof them. TLR1, K2 and K6 are triggered bypeptidoglycan and other microbial products, TLR3by dsRNA, TLR4 by LPS, TLR5 by flagellin, TLR7and K8 by imidazoquinolines, and TRL9 byunmethylated CpG DNA motifs. Although TLR3is a receptor for dsRNA and cellular mRNA,20,21 it
S
6
DTD 5 ARTICLE IN PRESS
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
does not contain dsRNA binding motifs. While thiswork is underway, a recent study has indicated theinvolvement of TLR3 in siRNA signaling andsuggested the involvement of dsRNA-bindingprotein that has yet to be identified.14 In contrastto macrophages and dendritic cells, however,human monocytes do not express TLR3 as assessedby flow cytometry and RT-PCR (Figure 3(a) and (b)).These results agree with those of a recent studyreporting on the expression of TLR3 by humanmonocytes.22 In addition, treatment of either adher-ent PBMC or purified monocytes with anti-TLR3monoclonal antibody, known to blocks TLR3signaling,23 did not inhibit the production of TNF-a by immunostimulatory siRNAs (data not shown).
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
Sense and antisense siRNA strands are highlystimulatory when compared to their double-stranded siRNA counterparts
The data described above indicate that a sub-group of double-stranded siRNAs can induce theproduction of inflammatory cytokines. During thisstudy, however, I have been surprised by thefinding that both single-stranded sense and anti-sense siRNAs can trigger the production of pro-inflammatory cytokines (e.g. TNF-a) andinterferons (IFN-a) in adherent PBMC (Figure 4 asa representative example). This is in contrast towhat have been reported using various cancer celllines.12,13 As for the double-stranded siRNAs, theinduction of TNF-a by single-stranded siRNAs wassequence dependent. In the case of siRNA 27, the
UNCO
RREC
T
After 18 hours transfection time, TNF-awas measured in thestranded and single-strand siRNAs. The test molecules (100 nelectroporation. To test the involvement of endosomes in siRNtwo hours with chloroquine prior to transfection with DOTAPsupernatants by ELISA. All results represent the mean of thr
YJMBI 57125—21/3/2005—17:12—SFORSTER—141115—XML – pp. 1–12/A
sense strand exhibited the strongest effects, whereasin the case of siRNA 32 the antisense strand exertedthe strongest effect on TNF-a production (Figure4(a)). Notably, the single-stranded siRNAs werehighly immunostimulatory compared to theirdouble-stranded siRNA counterparts (e.g. siRNA32). As shown DOTAP alone did not induce eitherTNF-a or IFN-a production, indicating that theeffects are related to the RNA sequences. Directaddition of either naked double-stranded siRNAsor single-stranded siRNAs did not affect cytokineproduction (data not shown). Moreover, severaldouble-stranded siRNAs did not induce response,whereas their corresponding single-stranded senseor antisense strands did (Figure 4(a), as anillustration). It is worth noting that the samesingle-stranded siRNA preparations were used toprepare the annealed siRNAs. Taken together, theseobservations would indicate that the reportedsiRNA effects in adherent PBMC are related to thesiRNA sequences and ague against any possiblecontamination with endotoxins.
ROOF
Cytokine induction by double-stranded siRNAs,sense or antisense siRNA strands requiresendosomal acidification
Cationic liposome-delivered siRNAs areexpected to enter the cell via endocytosis. Becauseseveral Toll-like receptors, in particular TLR7,TLR8, TLR9, are localized in the endosomes, Ihypothesized that endocytically introduced RNAcould trigger the activation of these receptors,
ED P
Figure 4. Effects of double-stranded and single-stranded siR-NAs upon TNF-a production inadherent PBMC. (a) Cells weretransfected with either double-stranded siRNAs (d), sensesiRNA strands (s) or antisensesiRNA strands (a) for 18 hours.Subsequently, TNF-a wasmeasured in the supernatants byELISA. All test RNA moleculeswere used at 100 nM and com-plexed with DOTAP at 10 mg/ml.(b) Inhibition of cytokine pro-duction by chloroquine in dose-dependent manner. Cells werepre-incubated with chloroquinefor two hours prior transfectionwith siRNAs (100 nM) for 18hours. Subsequently, TNF-a wasmeasured in the supernatants byELISA. (c) The test RNAmolecules(100 nM) were delivered to thecells either via DOTAP or electro-poration as indicated on the figure.
supernatants by ELISA. (d) Induction of IFN-a by double-M) were delivered to adherent PBMC via either DOTAP orA induction of interferons, cells were also pretreated for
. After transfection (20 hours), IFN-awas measured in theee or more independent experiments.
PPS
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
7
DTD 5 ARTICLE IN PRESS
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
leading MAPK kinases and NF-kB activation. Totest the involvement of endosomes in siRNAsignaling, cells were treated with an inhibitor oflysosomal acidification, chloroquine for two hoursprior to transfection with either double-strandedor single-stranded siRNAs. TNF-a secretion byadherent PBMCwere inhibited in a dose-dependentmanner by chloroquine (Figure 4(b)), indicating thatthe acidification of the endosomes is importantfor cellular response to either double-stranded orsingle-stranded siRNAs. A similar inhibition wasobtained with Bafilomycin, an additional inhibitorof endosomal acidification (data not shown).
Cationic liposomes such as DOTAP both protectthe siRNA and mediate internalization via endo-cytosis. After entry, the siRNA must escape theendolysosomes and enter the RNAi pathway.The requirement for acidification of endosomes inadherent PBMC was further examined via electro-poration of siRNAs into adherent PBMC. In contrastto DOTAP, the electroporation method open uppores in the cell, so siRNA molecules can enter thecell directly into the cytoplasm. As shown in Figure4(c) and (d), no TNF-a and IFN-a induction wasobtained when either double-stranded or single-stranded siRNAs were delivered via electropora-tion. Therefore, endosome compartments arerequired for both double-stranded and single-stranded siRNA intracellular signaling andsubsequent cytokines and interferon productionby adherent PBMC. Notably, pretreatment of PBMCwith chloroquine prior to transfection with siRNAabrogated IFN-a production (Figure 4(d)), indicat-ing for the first time the involvement of endosomesin siRNA induction of interferons.
UNCO
RREC
T
YJMBI 57125—21/3/2005—17:12—SFORSTER—141115—XML – pp. 1–12/APP
PRO
OF
Endosomal siRNA signaling supports theinvolvement of the Toll-like receptor 8
Toll-like receptors (TLRs) represent a class ofpattern recognition receptors (PPRs) that detectmicrobes or their components.19 TLRs are pre-dominantly expressed on the cell surface; however,a subset (TLR7, TLR8, TLR9, and in some cases,TLR3) is retained in intracellular compartments.Notably, TLR9, TLR7 and TLR8 require endosomalacidification for signaling.19 Because the inductionof inflammatory cytokines by siRNAs is chloro-quine-sensitive, the data would support the invol-vement of these receptors in siRNA intracellularsignaling. The recent identification of single-stranded RNAs as a ligand for human TLR824,25
would support our initial observation15 and thepresent elaborated results suggesting the involve-ment of endosomal TLRs in single-stranded siRNAsignaling. This novel observation invites the ques-tion of what serves as the endosomal receptors fordouble-stranded siRNAs. In acidic microenviron-ment such as the endosomes, double-strandedsiRNA might dissociate and generate single-stranded siRNAs for intracellular signaling. Insupport of this idea is the observation that certaindouble-stranded siRNAs are very less effective ininducing inflammatory cytokine production thantheir corresponding single-stranded sense or anti-sense strand counterparts (Figure 4). Depending ofthe relative internal stability, certain siRNAduplexes may exist in equilibrium with their singlestrand forms, which can activate TRL8 and/or otherendosomal TLRs (Figure 5). Alternatively, double-stranded siRNAs may signal through endosomalTLR3, known to bind double-stranded RNAs.21
ED
Figure 5. A schematic diagramillustrating the intracellular siRNAsignaling. A complex of eitherdouble-strand or single-strand siR-NAs or cationic lipids bind to theplasma membrane electrostaticallyand are internalized via endocyto-sis. Within the endosomes RNAmolecules can bind to endosomalToll-like receptors, in particularTLR8 and 7, which can activatethe transcription factor NF-kB,leading to inflammatory cytokineproduction. TLR7, 8 and 9 useMyD88 as primary adaptor toactivate interferon production viaundefined signaling intermediates.TLR3 uses the adaptor proteinTRIF to activate interferon regulat-ory factor-3 (IRF-3). The activationof Toll receptors may activate PKRdirectly.19,11
S
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
T
ROOF
Figure 6. Immunostimulatory siRNAs activate theNF-kB transcription factor. A NF-kB-dependent luciferasereporter gene was co-transfected in human adherentPBMC with a control plasmid containing the Renillaluciferase gene under the control of the CMV promoterfor 24 hours. Subsequently; cells were treated with eithersiRNA 27 or 32. The sense (S) and the antisense strand (A)of siRNA 27 and 32, respectively, were also tested.Eighteen hours later, luciferase activity was determinedusing Dual-Luciferase Reporter Assay System (Promega).The data show the relative firefly luciferase activitynormalized to that of Renilla luciferase. Results areshown as means of three independent experiments GSD.
8
DTD 5 ARTICLE IN PRESS
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
ORREC
Given that single-stranded siRNA are highlyimmunostimulatory compared to their correspond-ing double-stranded siRNAs, during siRNAannealing it is important to make sure that allsiRNA molecules exist as siRNA duplexes.Although all double-stranded siRNA preparationsused in this study were checked by PAGE for thepresence of unannealed single-stranded siRNAs,some of the double-stranded siRNA effects couldoriginate from tiny traces of free single-strandedsiRNAs. Whatever the nature of double-strandedsiRNA receptors; however, the present data indicatefor the first time that induction of inflammatorycytokines and interferon-a by either double-stranded or single-stranded siRNAs requires endo-somal acidification in fleshly isolated PBMC. There-fore, the development of carriers that deliver siRNAdirectly into the cytoplasm should overcome theproblem of inflammatory cytokine induction bychemically synthesized siRNA, a major obstacle forsystemic administration of siRNA in patients.Similarly to siRNA liposome complexes, nakedsiRNAs delivered via other techniques in vitro andin vivo are more likely to be taken up by cells viaendocytosis.
The finding that several siRNA sense strands(mRNA sequences) can be highly immunostimula-tory indicates that endosomal Toll-like receptorscan recognize self-RNA. Thus, how can the immunesystem distinguish between self and non-self RNAs(e.g. viral RNAs,) and how to mount and amplify animmune response against invading RNA in aspecific manner? The present data argue that theimmune system uses the endosomes or lysosomalcompartments as molecular recognition signaturefor RNA in general (whether self or non-self).In contrast to viral RNAs, self-RNAs exist in thecytoplasm and therefore cannot enter the endoso-mal compartments; hence in normal situation theimmune system cannot be activated by self-RNAs.Similar to single-stranded siRNAs, liposomaldelivery of short single-stranded RNA (21 nt)derived from HIV-1 TAT mRNA or human TNF-amRNA also induced TNF-a and IFN-a productionin adherent PBMC (data not shown). Thus, endo-somal location of RNA seems to function as a“danger signal” for TLR recognition, and sub-sequent activation of innate immunity genes. Theobservation that certain sequences are more stimu-latory than others would indicate that endosomalTLRs, in particular TLR8, have preferences for aparticular nucleotides and/or structures that needfurther investigation.
999
1000
1001
1002
1003
1004
1005
1006
1007
1008
UNCsiRNA treatment can activate the NF-kB
promoter
The core TLR signaling pathway uses myeloiddifferentiation factor 88 (MyD88) as the primaryadaptor protein and results in NF-kB activation,cytokine production and expression of costimula-tory molecules, such as the class II major histocom-patibility complex. To address the involvement of
YJMBI 57125—21/3/2005—17:12—SFORSTER—141115—XML – pp. 1–12/A
ED PNF-kB, promoter activation studies using fireflyluciferase as a reporter gene was performed.
Adherent PBMC were transiently transfected withNF-kB-luciferase gene along with plasmid DNAwith the Renilla luciferase gene for 24 hours.Subsequently, the cells were either mock transfectedor transfected with a stimulatory siRNA, and 18hours later, cells were harvested, and equalamounts of cell extracts were subjected to luciferaseassay (Figure 6). The data showed that double-stranded siRNA 27 could induce around 8-foldincrease in NF-kB activity, whereas 22-fold increasewere obtained with the single-stranded siRNA(S27), again identifying single-stranded siRNAs asan important inducer of NF-kB activation.
Single-stranded and double-stranded siRNAsstimulate monocyte-derived immature dendriticcells to produce cytokines and up-regulatecostimulatory molecules
If we view the induction of inflammatorycytokines as a beneficial mediator in cancer andinfectious diseases, then stimulatory siRNAs couldemerge as a viable agent to knockdown specificgenes and activate innate and acquired immunityagainst tumor cells. Notably, stimulation of imma-ture dendritic cells (iDC) by microbial productsinduces the production of inflammatory cytokines
PPS
T
Figure 7. Immature DC activatedwith siRNA upregulated theexpression of CD83 and secretedIL-12. Immature dendritic cellswere culture for 48 hours in thepresence of either siRNA 27 or 32(100 nM) and then stained withFITC-labeled monoclonal anti-bodies specific for CD83 (a). Cellswere also stained with the corre-sponding isotype control. Themean fluorescence of stained cellsis shown in the upper-right cornerof the individual dot plots. Resultsare shown as means of threeindependent experiments GSD.
(b) After 48 hours stimulation with siRNAs, IL-12 was measured in the supernatants using ELISA. Results are shownas means of three independent experiments GSD.
9
DTD 5 ARTICLE IN PRESS
1009
1010
1011
1012
1013
1014
1015
1016
1017
1018
1019
1020
1021
1022
1023
1024
1025
1026
1027
1028
1029
1030
1031
1032
1033
1034
1035
1036
1037
1038
1039
1040
1041
1042
1043
1044
1045
1046
1047
1048
1049
1050
1051
1052
1053
1054
1055
1056
1057
1058
1059
1060
1061
1062
1063
1064
1065
1066
1067
1068
1069
1070
1071
1072
1073
1074
1075
1076
1077
1078
1079
1080
1081
1082
1083
1084
1085
1086
1087
1088
1089
1090
1091
1092
1093
1094
1095
1096
1097
1098
1099
1100
1101
1102
1103
1104
1105
1106
1107
1108
1109
1110
1111
1112
1113
1114
1115
1116
1117
1118
1119
1120
1121
1122
1123
1124
1125
1126
1127
1128
1129
1130
1131
1132
1133
1134
UNCO
RREC
such as TNF-a and IL-12, which can inducedifferentiation of T cells into a T helper cell type1.26 In addition, these stimuli are known to up-regulate certain costimulatory molecules such asCD40, CD80, CD83 and CD86. This processunderlies DC maturation, and it strongly poten-tiates the ability of DC to activate naive T cells.26,27
Therefore, the effects of siRNAs upon the matu-ration of DC were investigated. To generate iDCs,freshly isolated monocytes were cultured for sixdays in the presence of GM-CSF (50 ng/ml) andIL-4 (100 ng/ml). Subsequently, they were bothtransfected with siRNA 27 or siRNA 32 and thenanalyzed by flow cytometry (Figure 7(a)). Addingstimulatory siRNA 27 to the culture mediumupregulated the expression of CD83, whereas nosignificant effects were obtained with the controlsiRNA 32. Treatment with siRNA 27 also upregu-lated the expression of CD86 (data not shown).Furthermore, siRNA 27-treatment resulted in IL-12production (Figure 7(b)). Similar results wereobtained with single-stranded siRNA 27. Theseresults suggest that stimulatory siRNAs canenhance immunity by inducing cytokine pro-duction and DC maturation. Thus, the use ofstimulatory double-stranded or single-strandedsiRNAs as a new generation of adjuvants mayfacilitate the design of effective vaccines.
The ability to enhance or augment the innateimmune response clearly represents a potentialpowerful way to prevent or treat infections as wellas a way to develop cancer vaccines. Recently, it hasbeen discovered that unmethylated CpG dinucleo-tides in particular base contexts are recognized bythe immune system as danger signals.28 In animalmodels, deoxyoligonucleotides with stimulatoryCpG motifs have been shown to be of therapeuticvalue as adjuvants for conventional and therapeuticvaccines against infectious diseases and tumors.29
As shown in the present study, the stimulatoryRNAs, in particular single-stranded siRNAs, acti-vated human monocytes and dendritic cells toproduce TNF-a and IL-12, two key cytokines inimmune regulation. In addition, the induction of
YJMBI 57125—21/3/2005—17:12—SFORSTER—141115—XML – pp. 1–12/APP
D PR
OOF
other cytokines such as IL-6 and interferons is anessential response for the clearance of viral infec-tions.30 Natural killer cells are activated by cyto-kines and chemokines, including type I IFN andIL-12, which are secreted by dendritic cells.31
Therefore, treatment of cancer and infectious dis-eases might benefit from the induction of cytokineand dendritic cell activation by immunostimulatorysiRNAs. TLR activators are already used asadjutants to boost immune responses in vaccines.However, the success of a given vaccine maydepend on appropriate activation of TLR. There-fore, single-stranded sense RNA-27 should beexplored as an adjuvant for vaccination andimmunotherapy. On the other hand, the develop-ment of TLR antagonist holds promise as a newclass of anti-inflammatory agents. Although furtherstudy is required, some of the non-stimulatoryRNAs may function as antagonists.
ESelection of siRNA against human TNF-aOne of the key cytokines crucial to manybiological processes is TNF-a. Low levels of TNF-a produced by monocytes and tissue macrophagesunder physiological conditions are expected to beinvolved in maintaining cellular and tissue homeo-static. The production of TNF-a increases inresponse to microbial infection and tissue injury.Because of its important role in the pathogenesis ofa variety of inflammatory and immune diseases,TNF-a has been identified as a key target forpharmacological modulation.32 Therefore, thedevelopment of agents that specifically inhibitTNF-a may provide clinician with a valuablealternative to traditional disease-modifying anti-inflammatory drugs. In this respect, we have shownthat siRNA-targeting mouse TNF-a can delay theonset of LPS-induced sepsis.33 Out of 12 recentlytested siRNA targeting mouse TNF-a, siRNA 29(see Table 1), exhibited the greatest protective effect.To select, siRNAs against human TNF-a, several
siRNAs were designed (Table 2) and tested for theirinhibitory effect on siRNA 27-induced TNF-a
S
Table 2. Sequences of siRNAs targeting human TNF-a
SiRNAs Sequence (5 0–3 0) (Sense strand)
H1 GAGUGACAAGCCUGUAGCCTTH2 CUCAGCGCUGAGAUCAAUCTTH3 CUAGUGGUGCCAGCCGAUGTTH4 GCGUGGAGCUGAGAGAUAATT
10
DTD 5 ARTICLE IN PRESS
1135
1136
1137
1138
1139
1140
1141
1142
1143
1144
1145
1146
1147
1148
1149
1150
1151
1152
1153
1154
1155
1156
1157
1158
1159
1160
1161
1162
1163
1164
1165
1166
1167
1168
1169
1170
1171
1172
1173
1174
1175
1176
1177
1178
1179
1180
1181
1182
1183
1184
1185
1186
1187
1188
1189
1190
1191
1192
1193
1194
1195
1196
1197
1198
1199
1200
1201
1202
1203
1204
1205
1206
1207
1208
1209
1210
1211
1212
1213
1214
1215
1216
1217
1218
1219
1220
1221
1222
1223
1224
1225
1226
1227
1228
1229
1230
1231
production in adherent PBMC (Figure 8(a)). SomesiRNAs were effective in inhibiting TNF-a pro-duction, whereas others had no effects, thussuggesting the specificity of the inhibitory effects.When tested alone, the siRNA inhibitors signifi-cantly reduced LPS-induced TNF-a production byadherent human PBMC (Figure 8(b)). The utility ofthis selection assay may be extended to otherinflammatory cytokines and type I interferon toselect effective siRNAs in human blood cells. It isworth noting that the immunostimulatory effects ofsiRNAs are more pronounced in human PBMC ascompared to other human cell lines. This maydepend on the expression level of Toll-like recep-tors, which is under investigation.
Collectively, the present study underscores forthe first time the importance of the endosomecompartments in siRNA intracellular signaling inadherent PBMC. The results can easily be explainedby the interaction of RNA molecules with endo-somal Toll-like receptors and subsequent inductionof inflammatory and interferon responses (seeFigure 5). The finding that endosomal localizationof self RNA can trigger Toll-like receptors signalingin adherent PBMC is intriguing because it indicates
UNCO
RREC
T
Figure 8. Selection of siRNAs against human TNF-a.(a) Inhibitory effects of TNF-a siRNAs on TNF-aproduction by the immunostimulatory siRNA 27. Adher-ent PBMC cells were co transfected with siRNA 27 andvarious siRNA targeting the human TNF-a (H1-5).Eighteen hours later supernatants were analyzed forTNF-a contents by ELISA. Results are shown as means ofthree independent experiments GSD. (b) Blockage ofLPS-induced TNF-a expression by the inhibitory siRNAs.The cells were transfected for 18 hours with either siRNA32, H2, H3 or H4 (50 nM). Subsequently, cells werestimulated with LPS (20 ng/ml) for eight hours and thensupernatants were analyzed for TNF-a contents byELISA. Results are shown as means of three independentexperiments GSD.
YJMBI 57125—21/3/2005—17:12—SFORSTER—141115—XML – pp. 1–12/A
that endosomal self RNA can display a molecularpattern capable for triggering innate immunityactivation.
1232
1233
1234
1235
1236
1237
1238
1239
1240
1241
1242
1243
1244
1245
1246
1247
1248
1249
1250
1251
1252
1253
1254
1255
1256
1257
1258
1259
1260
ED P
ROOF
Experimental Procedures
siRNAs
The siRNAs used in this study correspond to variousmolecules targeting genes related to other ongoingprojects. All siRNAs were chemically synthesized byEurogentec (Seraing, Belgium), dissolved in water andannealed in the transfection buffer (20 mM Hepes,150 mM NaCl, pH 7.4) at 20 mM. Analysis of LPS/endo-toxin levels in siRNA stocks was found to be less than0.01 EU/ml (PyrogentR, CAMBREX). The sequencesof the sense strands and the target genes are shown inTable 1.
Preparation of human cells
Human mononuclear cells were prepared from buffycoats by density gradient centrifugation (Lymphoprep,Nycomed Pharm, Oslo), washed, and then resuspendedin RPMI 1640 containing 10% heated inactivated fetal calfserum (FCS). Enriched monocyte populations wereisolated by plastic adherence. After three hours incu-bation at 37 8C, non-adherent cells were removed byrepeated gentle washing with warm medium. More than75% of the obtained cells by this technique are CD14Ccells. In addition, CD14C cell population was preparedfrom PBMC by positive selection with immunomagneticbeads coated with anti-CD14 monoclonal antibodies(Dynal, Oslo, Norway).
Culture of dendritic cells
Enriched population of CD14 positive monocytes wereisolated from human PBMC as described above andcultured for five days in RPMI 1640 supplemented with10% FCS and antibiotics, in the presence of 50 ng/ml GM-CSF and 100 ng/ml IL-4 to obtain monocyte- derivedimmature dendritic cells (iDC). After five days in culture,the cells were either mock transfected or transfected witheither siRNA 27 or 32 for 48 hours, and then cells werestained with FITC-conjugated monoclonal antibodiesspecific for CD83 (Immunotech). Cells were also stainedwith FITC-conjugated normal mouse IgG1, an isotypecontrol.
FACS staining and analysis
Briefly, 2!105 cells were incubated in the recom-mended FITC-labeled antibody dilutions for 30 minutesat 4 8C in staining buffer (PBS containing 0.5% FCS and0.1% azide). Cells were also stained with the correspond-ing Ab isotype controls. Subsequently, the cells werewashed twice with the staining buffer and then analyzedon a FACScan using Cell-Quest software (BD Bio-sciences). Cells were gated in forward/side scatter andthe quadrants were set on the relative isotype controls.
Transfection and ELISA
Cells were seeded at 5!104/well/200 ml in 96-wellplates. After an overnight incubation with siRNAs/lipo-some complexes, culture supernatants were collected and
PPS
11
DTD 5 ARTICLE IN PRESS
1261
1262
1263
1264
1265
1266
1267
1268
1269
1270
1271
1272
1273
1274
1275
1276
1277
1278
1279
1280
1281
1282
1283
1284
1285
1286
1287
1288
1289
1290
1291
1292
1293
1294
1295
1296
1297
1298
1299
1300
1301
1302
1303
1304
1305
1306
1307
1308
1309
1310
1311
1312
1313
1314
1315
1316
1317
1318
1319
1320
1321
1322
1323
1324
1325
1326
1327
1328
1329
1330
1331
1332
1333
1334
1335
1336
1337
1338
1339
1340
cytokine contents were assessed by ELISA. Cells weretransfected in RPMI 1640 medium (PAA LaboratoriesGmbH) supplemented with 10% heat-inactivated FCS,2 mM L-glutamine, 100 mg/ml penicillin and 100 mg/mlstreptomycin using DOTAP (10 mg/ml) as described.33
Each assay was carried out in triplicate. When nakedsiRNAs were used, cells were incubated in X-VIVO 15medium without adding FCS (CAMBREX). In the caseof monocytes, 2!104 cells were used per well. Theinactivation of PKR was carried out as follows: Cells wereincubated with 2-aminopurine (10 mM), a specific inhibi-tor of PKR, for one hour prior to addition of the siRNA/liposome complexes. After an overnight transfectionwith the tested molecules, the levels of TNF-a, IL-6 andIL-12p70 in the culture supernatants were measured byavailable ELISA kits according to the manufacture’sinstructions (R&D Pharmingen). Samples were run intriplicate. Human IFN-a was measured using ELISA kit(PBL Biomedical Laboratories).
1341
1342
1343
1344
1345
1346
1347
1348
1349
1350
1351
1352
1353
1354
Transfection and reporter assays
An enriched monocyte population (2!106 cells) wereseeded onto a 24-well plate and transfected the followingday with firefly luciferase gene (1 mg) under the control ofthe NF-kB-promoter and pRL-TK DNA (1 mg, Promega)encoding the Renilla luciferase gene. After 24 hours, thecells were transfected with siRNAs and then cells wereharvested 18 hours later. Luciferase activities weremeasured using the Dual-Luciferase Reporter AssaySystem according to the manufacture’s instructions(Promega).
T
1355
1356
1357
1358
1359
1360
1361
1362
1363
1364
1365
RT-PCR analysis
Total RNA was extracted from freshly isolated mono-cytes and monocytes-derived iDC using total RNAisolation kit (Pharmacia Biotech). DNAse I-treated RNA(10 mg) was reverse-transcribed with NotI-d(T)18 primerusing the first-strand cDNA synthesis Kit (PharmaciaBiotech) according to the manufacturer’s instructions.Polymerase chain reaction (PCR) was performed on 3 mlof cDNA in 50 ml of final volume. The TLR3 primers are:
1366
1367
YJM
1368
C5 0-ATTGGGTCTGGGAACATTTCTCTTC-3 0 (forwardprimer)
1369
1370
1371
1372
RE
5 0-GTGAGATTTAAACATTCCTCTTCGC-3 0 (reverseprimer)
As a control, b actin mRNA was also amplified usingthe following primers:
1373
1374
1375
R5 0-ATCTGGCACCACACCTTCTACAATGAGCTGCG-3 0 (forward primer)
1376
1377
1378
1379
1380
NCO50-CGTCATACTCCTGCTTGGTGATCCACATCTGC-30After 35 cycles of amplification (one minute at 92 8C;one minute at 56 8C; one minute at 72 8C, samples wereanalyzed by electrophoresis on 1.5% agarose gel andvisualized by ethidium bromide staining.
U 138113821383
1384
1385
1386
Uncited Reference
34.
BI 57125—21/3/2005—17:12—SFORSTER—141115—XML – pp. 1–12/APP
Acknowledgements
I thank Drs Per Ole Iversen and Anne Dybwadfor critical reading of the manuscript, and LiseForfang for excellent technical assistance with flowcytometry. This work was supported by theNorwegian Cancer Society.
ED P
ROOF
References
1. Fire, A., Xu, S., Montgomery, M. K., Kostas, S. A.,Driver, S. E. & Mello, C. C. (1998). Potent and specificgenetic interference by double-stranded RNA inCaenorhabditis elegans. Nature, 391, 806–811.
2. Hannon, G. J. (2002). RNA interference. Nature, 418,244–251.
3. Hamilton, A. J. & Baulcombe, D. C. (1999). A speciesof small antisense RNA in posttranscriptional genesilencing in plants. Science, 286, 950–952.
4. Sen, G. C. (2001). Viruses and interferons. Annu. Rev.Microbiol. 55, 255–281.
5. Saunders, L. R. & Barber, G. N. (2003). The dsRNAbinding protein family: critical roles, diverse cellularfunctions. FASEB J. 17, 961–983.
6. Elbashir, S. M., Harborth, M. J., Ledecknel, W., Yalcin,A., Weber, K. & Tuchl, T. (2001). Duplexes of 21-nucleotide RNAs mediate RNA interference incultured mammalian cells. Nature, 411, 494–498.
7. Sioud, M. (2004). Therapeutic siRNAs. Trends Pharma-col. Sci. 25, 22–24.
8. Hannon, G. J. & Rossi, J. J. (2004). Unlocking thepotential of the human genome with RNA inter-ference. Nature, 431, 371–378.
9. Kawasaki, H. & Taira, K. (2004). Induction of DNAmethylation and gene silencing by short interferingRNAs in human cells. Nature, 431, 211–217.
10. Semizarov, D. et al. (2003). Specificity of shortinterfering RNA determined through gene expressionsignatures. Proc. Natl Acad. Sci. USA, 100, 6347–6352.
11. Persengiev, S. P., Zhu, X. & Green, M. R. (2004).Nonspecific, concentration-dependent stimulationand repression of mammalian gene expression bysmall interfering RNAs (siRNAs). RNA, 10, 12–18.
12. Sledz, C. A., Holko, M., de Veer, M. J., Silverman, R. H.& Williams, B. R. G. (2003). Activation of theinterferon system by short-interfering RNAs. NatureCell. Biol. 5, 834–8340.
13. Bridge, A. J., Pebernard, S., Ducraux, A., Nicoulaz,A.-L. & Iggio, R. (2003). Induction of an interferonresponse by RNAi vectors in mammalian cells.NatureGen. 34, 263–264.
14. Kariko, K., Bhuyan, P., Capodici, J. & Weissman, D.(2004). Small interfering RNAs mediate sequence-independent gene suppression and induce immuneactivation by signaling through Toll-like receptor 3.J. Immunol. 172, 6545–6549.
15. Sioud, M. & Sørensen, D. R. (2003). Cationic liposome-mediated delivery of siRNAs in adult mice. Biochem.Biophys. Res. Commun. 312, 1220–1225.
16. Kim, D-H. , Longo, M., Han, Y., Lundberg, P., Cantin,E. & Rossi, J. J. (2004). Interferon induction by siRNAsand ssRNAs synthesized by phage polymerase.Nature Biotechnol. 22, 312–325.
17. Medzhitov, R., Preston-Hurlburt, P. & Janeway, C. A.,Jr (1997). A human homologue of drosophila Tollprotein signals activation of adaptive immunity.Nature, 388, 394–397.
S
12
DTD 5 ARTICLE IN PRESS
1387
1388
1389
1390
1391
1392
1393
1394
1395
1396
1397
1398
1399
1400
1401
1402
1403
1404
1405
1406
1407
1408
1409
1410
1411
1412
1413
1414
1415
1416
1417
1418
1419
1420
1421
1422
1423
1424
1425
1426
1427
1428
1429
1430
1431
1432
1433
1434
1435
1436
1437
1438
1439
1440
1441
1442
1443
1444
1445
1446
1447
1448
1449
1450
1451
1452
1453
1454
1455
1456
1457
1458
1459
1460
1461
1462
1463
1464
1465
1466
1467
1468
1469
1470
1471
1472
1473
1474
1475
1476
1477
18. Aderem, A. & Ulevitch, R. J. (2000). Toll-like receptorsin the induction of the innate immune response.Nature, 406, 782–787.
19. Armant, M. A. & Fenton, M. J. (2002). Toll-likereceptors: a family of pattern recognition receptorsin mammals. Gen. Biol. 3, 3011.
20. Alexopoulou, L., Holt, A. C., Medzhitov, R. & Flavell,R. A. (2001). Recognition of double-stranded RNAand activation of NF- kappa B by Toll-like receptor 3.Nature, 413, 732–738.
21. Kariko, K., Ni, H., Capodici, J., Lamphier, M. &Weissman, D. (2004). mRNA is an endogenous ligandfor Toll-like receptor 3. J. Biol. Chem. 279, 12542–12550.
22. Matsumoto, M., Funami, K., Tanabe, M., Oshiumi, H.,Shingai, M., Seto, Y. et al. (2003). Subcellular localiz-ation of Toll-like receptor 3 in human dendritic cells.J. Immunol. 171, 3154–3162.
23. Matsumoto, M., Kikkawa, S., Kohase, M., Miyake, K.& Seya, T. (2002). Establishment of a monoclonalantibody against human Toll-like receptor 3 blocksdouble stranded RNA-mediated signaling. Biochem.Biophys. Res. Commun. 293, 1364–1369.
24. Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F.,Kirschning, C. & Akira, S. (2004). Species-specificrecognition of single-stranded RNA via toll-likereceptor 7 and 8. Science, 303, 1526–1529.
25. Diebold, S. S., Kaisho, T., Hemmi, H., Akira, S. &Sousa, C. R. (2004). Innate antiviral responses bymeans of TLR7-mediated recognition of single-stranded RNA. Science, 303, 1529–1531.
26. Langenkamp, A., Messi, M., Lanzavecchia, A. &
UNCO
RREC
T
YJMBI 57125—21/3/2005—17:12—SFORSTER—141115—XML – pp. 1–12/A
OF
Sallusto, F. (2000). Kinetics of dendritic cell activation:impact on priming of TH1, TH2 and nonpolarized Tcells. Nature Immunol. 1, 311–316.
27. Lutz, M. B. & Schuler, G. (2002). Immature, semi-mature and fully mature dendritic cells: which signalsinduce tolerance or immunity? Trends Immunol. 23,445–449.
28. Krieg, A. M. (1996). Lymphocyte activation by CpGdinucleotide motifs in prokaryotic DNA. TrendsMicrobiol. 4, 73–76.
29. Krieg, A. M., Love-Homan, L., Yi, A. K. & Harty, J. T.(1998). CpG DNA induces sustained IL-12 expressionin vivo and resistance to Listeria monocytogeneschallenge. J. Immunol. 161, 2428–2434.
30. Netea, M. G., van der Graaf, C., Van der Meer, J. W. M.& Kullberg, B. J. (2004). Toll-like receptors and thehost defense against microbial pathogens: bringingspecificity to the innate-immune system. J. Leukoc.Biol. 75, 749–755.
31. Raulet, D. H. (2004). Interplay of natural killer cellsand their receptors with the adaptive immuneresponse. Nature Immunol. 5, 996–1002.
32. Tracey, K. J. & Cerami, A. (1994). Tumour necrosisfactor: a pleiotropic cytokine and therapeutic targets.Ann. Rev. Med. 45, 491–503.
33. Sørensen, R. & Leirdal, M. (2003). Sioud M Genesilencing by systemic delivery of synthetic siRNAs inadult mice. J. Mol. Biol. 327, 761–766.
34. Sioud, M. (1994). Interaction between tumor necrosisfactor a ribozyme and cellular proteins. J. Mol. Biol.242, 619–629.
1478
1479
1480
O
Edited by J. Karn
R 148114821483
(Received 20 December 2004; received in revised form 3 March 2005; accepted 4 March 2005)ED P
PPS
1484
1485
1486
1487
1488
1489
1490
1491
1492
1493
1494
1495
1496
1497
1498
1499
1500
1501
1502
1503
1504
1505
1506
1507
1508
1509
1510
1511
1512
Induction of Inflammatory Cytokines by Double-stranded and Single-stranded siRNAs is Sequence-dependent and Requires Endosomal LocalizationIntroductionResults and DiscussionThe non-specific effects of siRNAs are sequence-dependentIntracellular siRNA delivery is required for cytokine inductionsiRNAs activate TNF-alpha production in purified human monocytesTLR3 is not required for responsiveness to either double-stranded or single-stranded siRNAs in adherent PBMCSense and antisense siRNA strands are highly stimulatory when compared to their double-stranded siRNA counterpartsCytokine induction by double-stranded siRNAs, sense or antisense siRNA strands requires endosomal acidificationEndosomal siRNA signaling supports the involvement of the Toll-like receptor 8siRNA treatment can activate the NF-kappaB promoterSingle-stranded and double-stranded siRNAs stimulate monocyte-derived immature dendritic cells to produce cytokines and up-regulate costimulatory moleculesSelection of siRNA against human TNF-alpha
Experimental ProceduressiRNAsPreparation of human cellsCulture of dendritic cellsFACS staining and analysisTransfection and ELISATransfection and reporter assaysRT-PCR analysis
Uncited ReferenceAcknowledgementsReferences